Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Avacopan. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Rh-catalyzed asymmetric hydrogenation avoids resolution, boosting yield to 42.55% for reliable API intermediate supply.
Solve chiral resolution challenges in avacopan synthesis with 63.59% yield and 98.8% ee. Reduce costs and scale efficiently for clinical and commercial supply.